You're Invited: Hormonal IUS Event
HORMONAL IUS UPDATES:
New Insights and Steps Toward Scale
Wednesday, June 24, 9:00am-11:00 EDT
Thursday, June 25, 9:00am-11:00 EDT
How can we continue to expand contraceptive method choice during the COVID-19 crisis?
Expanding contraceptive choice increases individuals’ ability to freely choose the family planning methods that best meet their reproductive desires and needs. Join us for a two-part virtual technical consultation to identify opportunities to expand access to the levonorgestrel intrauterine system (IUS) - also known as the hormonal IUS as part of a a broader method mix.
The hormonal IUS has important advantages:
- One of the most effective forms of long-acting reversible contraception available
- Can have fewer side effects than some other hormonal methods
- Offers non-contraceptive benefits such as reducing menstrual cramps and blood loss
- Potentially alleviates anemia in some populations
Despite these advantages, the hormonal IUS is not widely available in low- and middle-income countries. How can we overcome supply- and demand-side barriers to access?
Join the Method Choice Community of Practice, led by the Evidence to Action (E2A) Project, and the Hormonal IUS Access Group for this online event. Participants will:
Review key features of the hormonal IUS and current product availability in LMICs
Get updates from the Hormonal IUS Access Group
Increase understanding of current global evidence
Receive updates from Kenya, Madagascar, Nigeria, Zambia, and elsewhere
Share service delivery tools and identify gaps
Review and discuss updates to the global learning agenda
Discuss how to move forward - including during the COVID-19 pandemic
HIFA profile: Ados May is a Senior Technical Advisor at the IBP Initiative in the United States of America. email@example.com